AstraZeneca PLC- ADR operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC- ADR with three other
companies in this sector in the United States:
sales of $20.41 billion
of which 34%
of which 100%
was Pharmaceutical Products), and
Eli Lilly and Company
of which 35%
During the year ended December of 2015, sales at
AstraZeneca PLC- ADR were $24.71 billion.
decrease of 5.3%
versus 2014, when the company's sales were $26.10 billion.